Clarification
In reference to The Daily Star story published on January 28, 2020 titled “Renata to set foot in the US this year”, the drug maker sent in a clarification. Renata acknowledged that four of its products are registered in the US, but its manufacturing facilities are awaiting inspection by the US Food and Drug Administration.
Comments